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ABSTRACT
Oxidative DNA damage plays a role in disease de-
velopment and the aging process. A prominent par-
ticipant in orchestrating the repair of oxidative DNA
damage, particularly single-strand breaks, is the
scaffold protein XRCC1. A series of chronological
and biological aging parameters in XRCC1 hetero-
zygous (HZ) mice were examined. HZ and wild-type
(WT) C57BL/6 mice exhibit a similar median lifespan
of  26 months and a nearly identical maximal life
expectancy of  37 months. However, a number of
HZ animals (7 of 92) showed a propensity for ab-
dominal organ rupture, which may stem from devel-
opmental abnormalities given the prominent role of
XRCC1 in endoderm and mesoderm formation. For
other end-points evaluated—weight, fat compos-
ition, blood chemistries, condition of major organs,
tissues and relevant cell types, behavior, brain
volume and function, and chromosome and telomere
integrity—HZ mice exhibited by-and-large a normal
phenotype. Treatment of animals with the alkylating
agent azoxymethane resulted in both liver toxicity
and an increased incidence of precancerous lesions
in the colon of HZ mice. Our study indicates that
XRCC1 haploinsufficiency in mammals has little
effect on chronological longevity and many key bio-
logical markers of aging in the absence of environ-
mental challenges, but may adversely affect normal
animal development or increase disease suscepti-
bility to a relevant genotoxic exposure.
INTRODUCTION
Roughly 400 uracil bases and 10000 abasic sites have been
estimated to be formed per mammalian genome per day
due to spontaneous deamination of cytosine or hydrolysis
of the N-glycosidic bond (1). In addition, attack of DNA
by reactive oxygen species, which are generated during
normal cellular respiration, results in well over a
thousand oxidative base and sugar lesions per day. This
enormous load of endogenous DNA damage poses both a
mutagenic and cytotoxic threat to the cell, and must be
removed in order to preserve genome integrity. Cells have,
therefore, evolved a complex array of complementary
DNA repair mechanisms that function to recognize and
process speciﬁc types of DNA damage to restore the
genetic code back to its original state. In the absence of
efﬁcient DNA repair, individuals exhibit cancer predispos-
ition, susceptibility to neurodegeneration, and other
pathologies (2,3). Indeed, a component of the ‘free radical
(or oxidative stress) theory of aging’ proposes that the
gradual accumulation of DNA damage over the lifespan
of the organism leads to steady cellular decline and even-
tually organism death (4).
The primary repair system for coping with spontaneous
hydrolytic and free radical-induced DNA damage is base
excision repair (BER) (5). BER typically involves removal
of a base lesion, such as 8-oxoguanine (8-oxo-dG), by a
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diester bond at the resulting abasic site by an apurinic/
apyrimidinic (AP) endonuclease. Replacement of the
missing nucleotide(s) by a gap-ﬁlling polymerase is per-
formed either prior to or following DNA termini
clean-up, i.e. the generation of a 30-hydroxyl and
50-phosphate end. The ﬁnal step of BER is sealing of the
remaining nick by a DNA ligase (6).
X-ray repair cross-complementing protein 1 (XRCC1)
is a non-enzymatic scaffold protein that has been sug-
gested to have relevant interactions with several DNA
glycosylases, the major human AP endonuclease APE1,
the predominant gap-ﬁlling DNA polymerase POLb,
and DNA ligase IIIa (7). XRCC1 is a nuclear factor
that facilitates repair complex assembly and efﬁcient
single-strand break (SSB) resolution, and appears to be
excluded from the mitochondria (8). In addition to the
interactions above, XRCC1 communicates with several
specialized SSB repair proteins, namely polynucleotide
kinase/phosphatase (PNKP), tyrosyl-DNA phospho-
diesterase 1 (TDP1) and Aprataxin (APTX), which
excise frequent 30 or 50 blocking groups from DNA, such
as 30-phosphate, 30-tyrosyl and 50-AMP residues (9,10).
Notably, mutations in PNKP have been connected to
microcephaly, early-onset, intractable seizures, and devel-
opmental delay (11). Mutations in the latter two genes,
TDP1 and APTX, are causally linked to the
neurodegenerative disorders spinocerebellar ataxia with
axonal neuropathy (SCAN1) and ataxia-oculomotor
apraxia 1 (AOA1), respectively (12–14). Recent evidence
has also suggested a key role for XRCC1 in the protection
of neural cells against the genotoxicity of oxidative stress
(15), and in neurogenesis of cerebellar interneurons and
for hippocampal homeostasis (16). Finally, molecular epi-
demiology studies in humans indicate that impaired
function in XRCC1 may be associated with increased
cancer susceptibility (17).
XRCC1 is critical for cell survival upon exposure to
agents that generate BER-related DNA damage, such as
the alkylating agent methylmethane sulfonate (18), and
for suppression of sister chromatid exchange that occurs
during S phase as a result of recombinational repair
resolution of one-ended double-strand breaks (19). In
mice, deletion of both alleles of Xrcc1 leads to early em-
bryonic lethality, apparently as a result of dysfunctional
SSB repair and consequent apoptosis (20). We have
employed heterozygous (HZ or
+/ ) mice to explore the
consequences of XRCC1 haploinsufﬁciency on (i) aspects
of chronological and biological aging, with a particu-
lar focus on brain physiology and (ii) susceptibility to
exposure-dependent pathologies.
MATERIALS AND METHODS
Animal background, maintenance and husbandry
For the primary lifespan study and associated analysis
(e.g. blood chemistries, behavioral assessments, and
imaging), Xrcc1
+/  mice were rederived from cryopre-
served embryos (stock number 000219-EU) that had
been deposited by Dr Robert Tebbs and colleagues at
the Harlan/Missouri Center of the Mutant Mouse
Regional Resource Centers (MMRRC). Three HZ male
mice of  2 months of age were crossed with 2-month-old
WT C57BL/6 females (Jackson Laboratories, Bar Harbor,
ME) to establish the initial colony. Mice were maintained
under standard conditions in a pathogen-free, tempera-
ture- and air-controlled barrier environment within a
BioBubble enclosure (Fort Collins, CO, USA). Animals
were administered Harlan Laboratories (Madison, WI)
S2018SX Teklad Global 18% protein extruded rodent
diet and provided reverse osmosis water ad libitum
throughout the course of their lifespan by the NIA
Comparative Medicine Section (CMS). Rooms were
kept at a 12-h light/dark cycle, maintained at 70–74 F.
All animal experiments were carried out according to the
‘Guide for the Care and Use of Laboratory Animals’
(National Academy Press, USA, 1996) and were
approved by the NIA IACUC.
Weights were measured monthly, and overall animal
health status was monitored by a designated person
within the facility at least every other day, with increased
monitoring after the age of 18 months, when signs of mor-
bidity were more likely. Morbidity was used as the lifespan
endpoint; to minimize pain and distress, natural death was
not an endpoint. Except for those animals found dead
unexpectedly, mice were euthanized by CO2 overdose at
the ﬁrst sign of morbidity. The date of death, and as best
could be determined, the cause of death were recorded for
all mice in the study.
Genotyping and western blotting
DNA was isolated from mouse tails using a 96-well
genomic DNA puriﬁcation kit from BioPioneer, Inc.
(San Diego, CA, USA). The genotype was determined
by the NIA Genotyping Lab using isolated DNA and a
primer mix of m219 F (AAA CTT CTG GGT CAC CTC
TGG ATG), m219 Rwt (CTT AGG ATG GCA GGT
TCA AGA CCA) and m219 RNeo (TTG TGC CCA
GTC ATA GCC GAA TAG), in a two-step PCR of
94 C for 1min and 69 C for 2min for 35 cycles with
GoTaq polymerase from Promega (Madison, WI, USA).
Ampliﬁcation of WT chromosomal DNA produced a
major PCR product of 484bp, whereas ampliﬁcation of
HZ DNA generated multiple products of 484 and  700–
800bp (http://www.mmrrc.org/strains/219/ctr_protocol
.pdf).
Western blotting was carried out using the procedure of
Lee et al. (16). In brief, healthy HZ and WT mice were
sacriﬁced and their cerebellums were removed. The cere-
bellum was lysed in a prechilled dounce homogenizer in
50mM Tris, pH 7.5, 200mM NaCl, 1% Tween 20, 0.2%
NP40, 1mM NaF, 2mM PMSF, 1mM activated Na
Vanadate, and complete Mini EDTA-free protease inhibi-
tor (Roche, Basel, Switzerland). The lysate was
centrifuged (13000g at 4 C) to remove insoluble
material. Thirty microgram of the resulting cell extract
was separated on a NuPage MOPS gel (Invitrogen,
Carlsbad, CA, USA), and the resolved protein was
transferred to a PVDF membrane using standard proced-
ures. A rabbit polyclonal XRCC1 antibody (a kind gift
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Hospital) was used as the primary antibody, followed by
goat anti-rabbit HRP-conjugated secondary antibody
(Pierce Biotechnology, Rockford, IL, USA). Detection
was carried out using a Pierce Super signal kit. b-actin
levels were determined on the same blot to ensure equal
loading of protein extracts using a rabbit polyclonal
b-actin antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and the same secondary antibody above.
Necropsy and pathological/histological evaluation
Upon death or euthanasia, nearly all animals of the
lifespan study were pathologically evaluated using basic
necropsy procedures. This evaluation was conducted by
an NIA veterinary pathologist or project staff. In
addition, two healthy HZ and WT mice (one male and
one female for each genotype, all 18.5-month old) were
sent to BioReliance (Rockville, MD) for a thorough
pathological and histological evaluation of all major
organs and tissues. The procedure involved examination
and dissection of the animal viscera and carcass as
described in BioReliance SOPs. Tissues were collected
and ﬁxed in 10% neutral buffered formalin (NBF). The
tissues were then processed in the automated tissue pro-
cessor, embedded in parafﬁn, sectioned at 6 microns or
less, stained with hematoxylin and eosin, and evaluated
microscopically. Additional, more targeted pathological
and histological evaluation was carried out by
BioReliance on three WT male mice (8.75, 10.25 and
23.75 months of age), three WT female mice (8.75, 23.75
and 32.75 months), four HZ male mice (10.25, 15.15 and
26 months) and four HZ female mice (8.75, 23.75, 23.75
and 24 months). These animals were also examined by
BioReliance for (i) bone marrow cellularity using the
standard brush-smear technique for femurs and
(ii) blood cell counts and morphology by manual evalu-
ation of blood smears.
Blood chemistry analysis
A total of 20 mice (ﬁve HZ females, ﬁve HZ males, ﬁve
WT females and ﬁve WT males) were assessed for a
variety of blood chemistries at  4, 12 and 18 months of
age. Blood was collected from animals by retro-orbital
techniques into appropriate vials and immediately shipped
to BioReliance for analysis. Blood chemistries evaluated
included: albumin, alkaline phosphatase, amylase, blood
urea nitrogen, creatine, creatine kinase, cholesterol, glu-
cose, triglycerides, aspartate aminotransferase, calcium,
direct bilirubin, magnesium, phosphorus, total protein
and uric acid. Determination of statistical relevance was
performed using ANOVA-single factor.
Behavioral studies
A total of 24 mice (seven HZ females, six HZ males, ﬁve
WT females and six WT males) were assessed for general
activity, motor function and cognitive ability as described
below. The same mice were evaluated at each age point to
capture within-subject changes across their lifespan. All
of the behavioral data were analyzed using ANOVA,
followed by Tukey’s post hoc comparisons when
appropriate.
Open ﬁeld. To assess general activity, mice were evaluated
at 7–8, 13–14 and 19–20 months of age in open ﬁelds with
automated data collection via photobeam breaks (Med-
Associates, St. Albans, VT, USA). Each mouse was
tested once at each age indicated. The mice were placed
into the open ﬁeld for 30min and distance traveled was
recorded.
Rotarod. Mice were evaluated at the ages above for motor
function and coordination on an accelerating rotarod
(Med-Associates, St. Albans, VT). On day 1, the mice
were administered a habituation session requiring them
to remain on the rotarod moving at a constant speed of
4rpm for 30s. The following day each mouse was given
three trials, during which the rotarod started at 4rpm and
accelerated to 40rpm over a period of 5min. The
maximum trial length was 5min, and there was  30min
rest period between each trial. The mean across all three
trials was determined and used for statistical analysis.
Water maze. In order to assess cognitive function, mice
(19–20 months of age) were evaluated in the water maze
across 6 days of memory acquisition, with a probe test on
Day 7. During the acquisition/retention stage, mice were
given four trials per day (60s maximum) in the maze. Each
acquisition trial began with the mouse being placed into
the water, facing the wall, at a quasi-random location
within the maze (arbitrarily: N, S, E or W). Mice then
had to escape onto a hidden platform, which remained
in a ﬁxed location across all 6 days of acquisition. Once
on the platform, mice were allowed to rest for 30s before
being returned to a holding cage by the experimenter.
Mice failing to escape onto the platform within 60s were
placed onto the platform and allowed to remain there for
30s. For each individual trial, latency, path length and
swim speed were recorded using a video tracking system
(HVS Image, Buckingham, UK). The inter-trial interval
was 40min. During the probe test on Day 7, the platform
was removed and the mice were allowed to swim for 60s
to determine if they would show a preference for the
quadrant in which the platform had been located during
the acquisition phase.
Magnetic resonance imaging and spectroscopy
Brain imaging and analysis. Experiments evaluating brain
morphology and metabolite proﬁle with magnetic reson-
ance imaging (MRI) and spectroscopy (MRS) were per-
formed on six WT ( 22 months) and ﬁve HZ
( 22 months) male mice. Mice were anesthetized with
1.5% isoﬂurane in a mixture of O2/air administrated via
a face mask, and body temperature was maintained at
36±1  C during all procedures. Respiration was moni-
tored using thoracic pressure via an MR-compatible,
Model 1025 monitoring and gating system (SA instru-
ments Inc., Stony Brook, NY). Images were acquired on
a 7T/30-cm Bruker spectrometer, using a 35-mm inner
diameter whole body resonator for transmission and re-
ception. Multi-slice axial, sagittal and coronal images were
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sequence. MRI parameters included pulse repetition and
echo times of TR/TE=710ms/26.5ms, number of shots
per acquisition of NEX=2, ﬁeld of view of
FOV=3.0 3.0cm, slice thickness=1.0mm and matrix
size 256 128. The cerebellar volume was computed by
manually tracing the contour encompassing the cerebellar
tissue within each slice of the stacked images for each
mouse.
Brain spectroscopy. Localized water-suppressed
1H
spectra of the central cerebellum (voxel dimension
4 2.5 1.5 mm
3) were obtained by using the point reso-
lved spectroscopy (PRESS) sequence, with TR/TE=2.5s/
135ms, 160 signal averages, 1024 data points with a
spectral range of 10ppm and a total scan time of
 7min. The given value for TE was selected to provide
a degree of spectral editing, permitting more unambiguous
resonance quantiﬁcation. N-acetyl aspartate (NAA) was
quantiﬁed as a marker for neuron viability, with choline
(Cho) used for normalization. Statistical analysis was
performed using a two-tailed Student’s t-test, with
P<0.05 considered signiﬁcant. Data are presented as
mean±standard deviation (SD).
Imaging of abdominal fat and analysis. MRI was used to
evaluate abdominal fat in ﬁve WT ( 22 months) and ﬁve
HZ ( 22 months) female mice as described above for
brain imaging. A moderately T1-weighted spin echo
sequence was used, with and without VAPOR fat suppres-
sion (21). Parameters included TR/TE=390ms/13.2ms,
NEX=2, FOV=4.0 4.0cm (fat axial imaging) or
5.0 4.0cm (fat sagittal and coronal imaging), 1.0mm
slice thickness, and 256 128 matrix size. Adipose tissue
was quantiﬁed using ImageJ (22), according to the follow-
ing procedure. Image processing was performed by ﬁrst
multiplying fat-suppressed and non-suppressed images to
enhance contrast, and then applying an unsharp mask to
enhance edge deﬁnition. Segmentation into adipose and
non-adipose tissues was then implemented through k
means clustering. Subcutaneous and intra-abdominal
adipose tissues were manually delineated within each
slice of the stacked images for each mouse to permit meas-
urement of their respective volumes.
Chromosome aberration analysis
Two WT and 2 HZ male mice ( 26 months of age) were
injected with 0.1cc of 0.5% colchicine intraperitoneally.
After 30min period, animals were euthanized and the
femur was removed. Cells were ﬂushed—following distal
puncture of the bone—into a 15ml tube using a 1cc
syringe ﬁlled with 0.56% KCl. Cells were incubated for
15min at 37 C and then harvested at 400g for 5min. The
supernatant was removed and discarded, and 0.5ml of
ﬁxative (3:1 methanol:glacial acetic acid) was added
without disturbing the pellet. After a brief incubation in
ﬁxative, the solution was removed and replaced with fresh
ﬁxative. To prepare chromosome spreads, an aliquot of
the above bone marrow cells was dropped on a clean slide
and allowed to air dry. Subsequently, chromosomal DNA
was stained with Vector Vectashield (Burlingame, CA,
USA) Hardset Mounting Medium with DAPI. Samples
were covered with a cover slide and allowed to set over-
night away from light. Visualization of chromosome
spreads was performed with an Olympus (Center Valley,
PA, USA) Axiovert microscope at 100  magniﬁcation.
Metaphase spreads were evaluated for chromosome
number and abnormalities for each animal.
Telomeric ﬂuorescence in situ hybridization
(telomeric-FISH)
Metaphase spread preparation was carried out as above.
Telomeric-FISH was performed as previously described
(23), using Cy-3-labeled (CCCTAA)3 protein nucleic
acid (PNA; Applied Biosystems, Foster City, CA,USA)
as a probe. Metaphases were examined for telomere
abnormalities, including telomere signal free ends and
chromosome end-to-end fusions, with a Zeiss (Jena,
Germany) Axiophot ﬂuorescence microscope.
Bone marrow cell viability assay
Bone marrow cells were harvested from the femurs of two
HZ and two WT 4-month-old male mice essentially as
described above, but were grown in Iscove’s Modiﬁed
Dulbecco’s medium (IMDM) containing murine stem
cell factor [MSF at 100ng/ml (Peprotech, Rocky Hill,
NJ, USA)] and recombinant murine interluekin-6 [IL-6
at 200U/ml (Peprotech, Rocky Hill, NJ, USA)]. After
culturing in media for 24h at 20% O2/5% CO2, cells
were counted and split into either 96-well plates (cell via-
bility assay) or 6-well plates (chromosome analysis). For
the cell viability assay, cells were plated at 1 10
4 cells per
well in replicates of ﬁve. The cells were allowed to grow for
24h as above, and then exposed to various concentrations
of MMS (0, 0.3, 1, 3 or 10mM) for 1h. Cells were then
washed three times with 1  PBS, and grown for an add-
itional 48h in IMDM supplemented with MSF and IL-6.
Cell viability was determined using the cell proliferation
reagent WST-1 (Roche, Indianapolis, IN) following the
manufacturer’s standard procedure. In short, cells (in
100ml IMDM medium) were incubated with 10mlo f
WST-1 reagent for 1h and evaluated using a BioRad
(Hercules, CA) Benchmark Plus microplate spectropho-
tometer and Microplate Manager Software. A dual wave-
length (450 and 650nm) protocol was used to determine
the absorbance of the samples. Ex vivo chromosome
analysis was carried out as described above, with the fol-
lowing modiﬁcation. Instead of injecting colchicine into
the mice, colchicine (10mg/ml) was added to the IMDM
media 24h post-plating of a six-well plate (cell density of
1 10
5 cells per well). Cells were allowed to grow in the
presence of colchicine for 5h at 20% O2/5% CO2 before
preparation of chromosome spreads.
Treatments with high fat-diet or azoxymethane
Mice used in the two treatment paradigms [i.e. high-fat
diet (HFD) or azoxymethane (AOM) exposure] were
obtained and maintained as for the lifespan study. These
animals were maintained in ventilated cages (less than ﬁve
per cage) in a speciﬁc pathogen free facility at the
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(except for the HFD) and provided reverse osmosis water.
Rooms were kept at a 12-h light/dark cycle, maintained at
70–74F, 45–55% humidity with 28 changes per hour.
Mice were genotyped using similar procedures as for the
lifespan study.
In the HFD studies, 15 HZ and 15 WT mice were main-
tained on standard rodent chow (5053, Picolab,
Richmond, Indiana) containing 20% (wt/wt) protein,
4.5% fat (ether extract) and 55% carbohydrate (primarily
starch) beginning at the time of weaning. At 16 weeks of
age, ten mice of each genotype were switched to a high-fat,
high-sucrose (high caloric) diet (S3282; Bio-Serv,
Frenchtown, NJ, USA) containing 20% protein, 36%
fat (primarily lard) and 36% carbohydrate (primarily
sucrose) for 12 weeks. Food intake was measured every
3 weeks. Two to three mice of the same genotype were
housed per cage, and food intake was measured as the
weight of food per cage consumed over a 24-h period,
averaged between the number of mice in each cage.
Food was weighed three times in a row over the course
of 3 days, and averaged.
To evaluate the susceptibility of Xrcc1
+/  mice to
AOM-induced pathologies, 4-month-old HZ and WT
male littermates (N=13 and 15, respectively) were
injected with 10mg/kg AOM (Sigma cat# A2853)
intraperitoneally, once a week for six weeks. Three mice
of each genotype were injected with sterile diluent. All
mice were monitored and weighed weekly and terminated
6 weeks following the last injection. Livers were grossly
staged for lesion severity, and sections collected. Colons
were removed and ﬂushed with ice cold phosphate-
buffered saline, opened and stained with methylene blue.
The entire length of colon was used to count aberrant
crypt foci using a dissecting microscope. Liver and repre-
sentative colon sections were ﬁxed in 10% neutral buffered
formalin and subsequently stained with hematoxylin/eosin
for histopathological evaluation.
Histopathological scoring of the liver was based on:
Grade 1, no evidence of toxicity; Grade 2, mild focal
hepatocellular necrosis, with limited evidence of mild
focal hepatocellular hyperplasia and hypertrophy, mild
focal bile duct hyperplasia and perivascular inﬁltration
of mononuclear inﬂammatory cells consisting of lympho-
cytes and macrophages; Grade 3, moderate focal hepato-
cellular hyperplasia and hypertrophy with pyknotic nuclei
and hepatocyte necrosis, moderate focal bile duct hyper-
plasia and perivascular inﬁltration of lymphocytes and
macrophages, and occasional ﬁbroblasts; and Grade 4,
areas of extensive necrosis replaced by severe, multifocal
nodular hepatocellular hyperplasia and hypertrophy with
hepatocytes showing enlarged cytoplasm and mild vacu-
olation, karyomegaly, and marked variation of nuclear
size with multiple nucleoli. Grade 4 also included:locally
extensive multifocal biliary hypertrophy and hyperplasia
with marked biliary dilation and periductal inﬁltrates of
lymphocytes and macrophages; and severe, multifocal,
periportal inﬁltrates of mononuclear inﬂammatory cells
with an increased number of ﬁbroblasts suggestive of
early ﬁbrosis.
RESULTS
Crosses between C57BL/6 Xrcc1
+/  males and females
recapitulated the reported inviability of homozygous
knockout mice (20), as no null animals were observed
among the 27 pups genotyped (unpublished observation).
Given the incompatibility of deletion of both alleles of
Xrcc1 with life, we evaluated herein the impact of
XRCC1 heterozygosity on chronological and physiologic-
al aging parameters without exposure, and on disease sus-
ceptibility in the face of altered diet or an exogenous
challenge. The haploinsufﬁcient animal model may very
well recapitulate the reduced XRCC1 function phenotype
that apparently exists in the human population (24,25).
XRCC1 heterozygosity
We conﬁrmed that Xrcc1
+/  animals expressed reduced
levels of XRCC1 protein. Speciﬁcally, western blot
analysis of extracts prepared from the cerebellum of
1-month-old mice showed that HZ animals expressed
slightly <50% of XRCC1 protein relative to the WT
counterparts (Figure 1A). Quantitative RT-PCR of total
RNA and western blot analysis of extracts from spleen of
6 to 10-month-old animals also revealed roughly 60%
transcript and 60% protein in the HZ mice (data not
shown; Dr Patricia Gearhart, National Institute on
Aging, personal communication). In addition, we had
demonstrated previously that isolated Xrcc1
+/  primary
cerebellar granule cells exhibited increased DNA strand
break accumulation and apoptotic cell death following
menadione exposure relative to cells from WT littermates,
further supporting reduced XRCC1 activity (15).
Collectively, these results demonstrate that loss of one
allele of Xrcc1 results in reduced expression of XRCC1
in mice and cellular susceptibility to exogenous genotoxin
exposure (see also later).
Lifespan of HZ animals:chronological aging
As a general means of assessing the impact of XRCC1
haploinsufﬁciency on mouse health and longevity, we
determined the lifespan and, where possible, the cause of
death of 82 WT (44 male and 38 female) and 92 HZ (51
male and 41 female) C57BL/6 animals. As evident from
the data presented in Figure 1B, an XRCC1 deﬁciency had
no signiﬁcant effect on the median life expectancy ( 790
days), despite the early deaths of a subset of HZ animals
(see below), or the maximal lifespan of the animal, a con-
clusion that was not altered when the data was broken
into male and female categories (1153 days for the
longest lived WT male, 1168 days for the HZ male, 1162
days for the WT female and 1171 days for the HZ female).
When cause of death was evaluated, some differences
were noticed between genotypes. In particular, HZ males
and females (total of seven) showed a propensity for ab-
dominal organ rupture, which we have deﬁned in
this study as splitting of the organ within the abdominal
cavity, that was not seen in the WT counterparts (Table 1,
P=0.01). Speciﬁcally, ruptures of the bladder (two cases,
one male at 6 months and one female at 2 months), liver
(one case, male at 7 months) and pancreas (four cases, two
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months) were diagnosed. These ruptures caused large
amounts of blood and ﬂuid to be released into the abdom-
inal cavity and in some cases resulted in autolysis. In none
of the situations, however, was it clear whether the rupture
was due to a structural instability in the tissue of the organ
wall, a hemorrhaging of the organ’s blood vessels, or
another cause.
HZ males and females (total of three) also showed a few
life-shortening complications related to possible neuro-
logical deﬁcits that were not seen in the WT colony
(Table 1, P=0.1). In particular, two cases of ‘head
tilting to one side’ (one HZ male, 21 months and one
HZ female, 26 months) and one case of ‘impairment of
lower leg movement on one side of body’ (HZ male, 26
months), behaviors commonly associated with a stroke,
were observed.
The tumors observed during necropsy in the animals of
the lifespan study (Table 1) included several types,
although none were conﬁrmed through histological evalu-
ation. In WT males, six histocytic sarcomas, ﬁve
hepatocellular carcinomas, two thoracic tumors and one
urinary carcinoma were detected. In WT females, three
histocytic sarcomas, two hepatocellular carcinomas, and
one ovarian cancer were observed, as was a case of general
metastasis without a known precursor. In HZ males, three
histocytic sarcomas and three hepatocellular carcinomas
were seen. In HZ females, three histocytic sarcomas, one
lymphoid tumor, and one case of general metastasis
without known precursor was recorded. Although there
is an apparently statistically signiﬁcant lower tumor fre-
quency in the HZ males relative to the WT males
(P=0.007, Chi-square contingency table analysis), inde-
pendent conﬁrmatory studies are needed to conclude that
XRCC1 deﬁciency has a beneﬁcial effect on sex-dependent
spontaneous cancer risk.
Physiological aging of HZ animals
We also assessed the following measurable end-points to
determine the effect of Xrcc1 heterozygosity on the
animal’s physiological age or condition.
Histology. An extensive necropsy was performed on two
healthy HZ and WT mice (one male and one female for
each genotype at 18.5 months of age) as described in
‘Materials and Methods’ section. Upon preparation, the
following tissues were evaluated and found to exhibit
normal histological morphology regardless of genotype
and sex: lung, thymus, spleen, liver, kidney, heart,
trachea, ileum, cecum, colon, brain with middle ears and
nasal cavity with eyes (data not shown).
In light of the organ ruptures noted above, which may
stem from developmental abnormalities during endoderm
or mesoderm formation, an additional set of animals were
analyzed (three WT males, three WT females, four HZ
males and four HZ females; see ‘Materials and Methods’
section) and the integrity of relevant tissues evaluated,
such as the pancreas and thyroid. Pathological and histo-
logical analysis, which included examination of the liver,
spleen, heart, brain, lung, testes/ovaries and bone marrow/
femur, in addition to the pancreas and thyroid, found that
all animals exhibited normal histopathology in line with
their age. Analysis of these 14 mice indicated three cases of
cancer: histiocytic sarcoma was noted in two of the WT
Figure 1. (A) Western blot analysis. Two HZ and two WT cerebellar
extracts were analyzed via western blot analysis. Top: An anti-XRCC1
rabbit polyclonal antibody was used as the primary antibody. Bottom:
b-actin levels were measured to ensure equal loading of lanes. The
XRCC1: b-actin ratio [determined from a scanned image of the
western blot autoradiograph using ImageQuant software (GE
Healthcare, Piscataway, NJ)] normalized to the WT extract denoted
1.0 is indicated below each lane. (B) Lifespan plot. Percentage of
mice alive is plotted against age in months for WT male (WTM),
WT female (WTF), HZ male (HZM), and HZ female (HZF). Total
animals per group were as follows: 82 WT (44 male and 38 female)
and 92 HZ (51 male and 41 female).
Table 1. Cause of death (COD)
Mouse genotype
and gender
COD
Infection Tumor ND Abdominal
issue
Other
A* B C** D
WTM (44) 6 14 19 0 3 0 2
WTF (38) 7 6 22 0 2 0 1
HZM (51) 6 5 30 4 2 2 2
HZF(41) 5 6 18 3 4 1 4
The total number of animals for each genotype (wild type=WT,
heterozygous=HZ) and gender (male=M, female=F) are indicated
in parentheses to the left. The number of animals for each COD clas-
siﬁcation is also indicated. A=organ rupture, B=autolysis,
C=neurological and D=other (malocclusion, prolapse, etc.).
ND=not determinable (or natural). Chi-square contingency table
analysis: *P=0.01, **P=0.1.
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bronchiolar adenoma was noted in another WT mouse
(male, 23.75 months). All of these cancers, as well as
several other non-neoplastic lesions observed in some of
the 14 animals, are considered spontaneous/background
ﬁndings typical for any strain of mouse.
In all but one (WT, female, 32.75 months) of the 14
animals, bone marrow analysis revealed normal cellularity
and a heterogeneous population, with erythroid, myeloid
and megokaryocyte precursors present and in adequate
number. In the case of the aberrant animal, a population
of pleomorphic neoplastic cells with large variable nuclei
and abundant cytoplasm (i.e. suggestive of a malignancy
of undetermined origin) was identiﬁed; this population
is most likely attributable to the histiocytic sarcoma
diagnosed in multiple organs in this WT female mouse.
For the manual complete blood count (CBC) analysis,
there was no difference in the composition or morphology
of the various blood cell types (neutrophils, basophils, eo-
sinophils, lymphocytes and monocytes), which were found
to be within the normal limits, with the exception of the
WT female mouse (23.75 months) noted earlier. This par-
ticular animal showed markedly poor cellularity with rare
lymphocytes and neutrophils present, most likely due to
the neoplasm outlined above.
Weight. Previous studies have suggested a possible in-
volvement of BER in obesity, dyslipidemia and fatty
liver disease, as a deﬁciency in the DNA glycosylase
NEIL1 results in a physiological state that mimics
human metabolic syndrome (26). As seen in Figure 2,
mice gained weight in an age-related manner up to  20
months of age. The Xrcc1
+/  animals, independent of
gender, displayed no obvious weight differences at any
age relative to the age-matched WT controls.
We previously demonstrated that a HFD given to
young adult male mice on a C57BL6 genetic background
can simulate an age-related weight gain (caused by an
increase in fat mass), as well as increase inﬂammatory
stress and down-regulate XRCC1 expression in intestinal
polyps [(27) and unpublished data]. We hypothesized that
HZ mice might be sensitive to a HFD, since levels of
XRCC1 protein are diminished. After 12 weeks on the
HFD starting at four months of age, HZ mice gained an
average of 13gm (29% increase) compared to WT mice,
which gained an average of 10g (23% increase) with no
statistical difference. These observations agree with the
similarity in body weights of the different genotypes of
old mice, and re-afﬁrm that obesity is not related to
XRCC1 haploinsufﬁciency.
Blood chemistries. To assess the overall health status, as
well as the functions of various organs in the HZ mice, a
series of blood chemistry tests were performed at 4, 12 and
18 months of age. Parameters analyzed included: albumin,
alkaline phosphatase, amylase, blood urea nitrogen,
creatine, creatine kinase, cholesterol, glucose, triglycer-
ides, aspartate aminotransferase, calcium, direct bilirubin,
magnesium, phosphorus, total protein and uric acid. For
nearly all measurements, HZ mice exhibited statistically
similar values to those determined for the age-matched
WT counterparts at each life stage (Supplementary
Table S1). The possible exceptions for the HZ animals
included elevated albumin (ALB, P-values: 0.00013—
males; 0.009—females) and creatine phosphokinase
(CPK, P-values: 0.004—males; 0.14—females) at 12
months, and although statistically insigniﬁcant, apparent
trends for decreased bilirubin at 4 months (DBL), and
elevated blood urea nitrogen (BUN) and phosphorus
(PHOS) primarily in the older mice.
Behavioral attributes. Given the association between
defects in SSB repair and neurological abnormalities
(10), we examined the impact of Xrcc1 heterozygosity on
brain function by evaluating: general activity levels, gross
locomotor activity and exploration habits (via open ﬁeld);
motor coordination, balance and equilibrium (via
rotarod); and spatial memory (via water maze). In the
open ﬁeld there were no genotype differences for distance
traveled, but there was an overall decrease at 19–20
months of age (F(2,38)=14.33, P<0.001; Figure 3A).
Evaluation of motor function and coordination indicated
no statistically signiﬁcant differences between sex-matched
WT or HZ animals, although there was a consistent trend
at each age analyzed for the HZ males to exhibit reduced
time on the rotarod (Figure 3B). An expected, overall
decrease in the ability of all animal categories to remain
on the accelerating rotarod was seen with age
(F(2,38)=15.02, P<0.001).
For the water maze, there was a general effect of‘days of
training’ for latency (F(5,100)=23.25, P<0.001) and path
length (F(5,100)=32.37, P<0.001), indicating that all
mice, regardless of genotype, were able to learn
(Supplementary Figure S1A and B). However, there was
no statistically signiﬁcant difference between the various
groups for either of these measures at any of the days of
acquisition. There were also no group differences for swim
speed, indicating that there was no XRCC1-dependent
effect on aptitude to perform in the water maze
(Supplementary Figure S1C). For the probe test, there
was no disparity between the groups in their preference
Figure 2. Weight plot: Weight in grams is plotted (using polynomial
line of best ﬁt) against age in months for WTM, WTF, HZM and
HZF. Each line is comprised of 371–427 data points, including 2–20
measurements for each of the 174 animals during their lifespan.
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located during acquisition (F(9.60)=1.36, P=0.225),
indicating that both WT and HZ animals were able to
learn and remember the location of the hidden platform
equally well (Supplementary Figure S1D).
Organ and tissue status. Again, given the reported associ-
ation of SSB repair defects with neurodegeneration, and
since the rotarod studies herein suggested a possible
impairment in motor coordination for HZ male mice
(Figure 3B), we employed MRI and MRS studies on
age-matched WT and HZ male animals to determine
relative brain dimensions and volume, and brain metabol-
ite (NAA:Cho) ratios, the latter of which permits an as-
sessment of local neuronal viability and function. In
addition, since prior studies suggested a role for BER
defects in obesity (26), we employed MRI to determine
intra-abdominal fat (IAF) and subcutaneous fat (SF) in
age-matched WT and HZ female mice.
Figure 4A shows the results of brain MRI and MRS
performed on six WT and ﬁve HZ  18-month-old male
mice. Typical image slices are shown along the three or-
thogonal axes, as well as a typical spectrum obtained from
the indicated voxel (Figure 4A, left). No statistically sig-
niﬁcant difference was observed in cerebellum volume
between the WT and HZ age-matched groups (Figure 4A,
right). For the MRS study, high-quality PRESS-localized
1H spectra were obtained with the selected value of
TE=135ms, which permitted editing of lipid and clear
delineation of the resonances for choline, creatine and
NAA (Figure 4A, lower left panel). No difference in
neuronal viability was identiﬁed between the WT and
HZ age-matched male animals as measured by the
NAA/Cho ratio (WT, 0.90±0.32; HZ, 0.88±0.42). We
note that for both MRI volume and MRS measurements
of neuronal viability, a larger variability in the data was
seen with the Xrcc1
+/  animals.
Abdominal MRI was performed on six WT and ﬁve HZ
 22-month-old female mice. Typical coronal (top) and
axial (bottom) slices with T1-weighting are shown in
Figure 4B (left). The volumes of IAF and SF for individ-
ual mice were determined from image segmentation along
axial, sagittal and coronal sections and averaged. Results
normalized individually by body weight (Figure 4B, right)
revealed no statistically signiﬁcant difference between
groups for total fat (IAF+SF) (WT: 157.3±59.9mm
3/g;
HZ: 169.3±84.4mm
3/g) or IAF (WT: 79.0±30.7mm
3/g;
HZ: 83.5±39.7mm
3/g). The two experimental groups
also did not differ in total fat or intra-abdominal fat
Figure 3. Open ﬁeld and rotarod analysis. (A) Mean distance traveled (±SEM) in the open ﬁeld during 30min sessions evaluated at 7–8 or 19–20
months of age for WTM, WTF, HZM and HZF mice. (B) Mean latency (±SEM) to fall from the accelerating rotarod when evaluated at 7–8, 13–14
or 19–20 months of age.
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(data not shown).
Effect of Xrcc1 heterozygosity on spontaneous genomic
instability in vivo
To assess the effect of Xrcc1 heterozygosity on genetic
stability in vivo, bone marrow cells were isolated from
WT and HZ 26-month-old mice (two each) following
intraperitoneal administration of colchicine and
examined for spontaneous chromosome and telomere
abnormalities. Speciﬁcally, metaphase spreads were
evaluated for chromosome number and overall integrity,
i.e. breakage, fragmentation, or other gross chromosomal
rearrangements, as well as telomere signal free ends or
end-to-end fusions. These studies revealed that Xrcc1
+/ 
mouse cells show no obvious chromosomal or telomere
alterations (Supplementary Figure S2, Table 2, and data
not shown), suggesting that XRCC1 heterozygosity has no
effect on spontaneous genomic instability. This conclusion
was supported by the fact that HZ bone marrow cells
displayed a normal cell cycle proﬁle with 2N DNA
content as assessed by ﬂuorescence activated cell sorting
(FACS) analysis (data not shown).
Analysis of bone marrow cells isolated from two
additional WT and HZ male mice (4 months of age)
found no overt chromosome abnormalities, including
fragmentation, breakage or fusions, following culturing
and treatment with colchicine ex vivo (data not shown).
Aneuploidy was observed in 3 of 49 and 8 of 48 meta-
phase spreads from the two WT mice, and 9 of 48 and 9
of 46 from the HZ animals (P=0.13 when comparing
the combined results; Chi-square contingency table
analysis), further supporting no statistically signiﬁcant
difference in chromosome stability between the two
genotypes.
Figure 4. Brain and fat imaging. (A) MR brain imaging and spectroscopy. Left: T2-weighted axial (upper left), sagittal (upper right) and coronal
images (lower right) through the cerebellum of an Xrcc1
+/  male mouse. Proton spectrum (lower left) acquired from the indicated voxel (PRESS
localization; TE=135ms) as used to quantify the NAA/choline ratio (see text). Right: Cerebellar volumes for the WT (67.3±4.9mm
3) and HZ
(65.5±6.8mm
3) male mice. (B) Abdominal fat imaging. Left: T1-weighted MR images without fat suppression acquired from a WT female (left
column) and a HZ female (right column), respectively. The position of the axial slices (bottom row) is as indicated by the arrows shown in the
coronal slices (top row). Fat is bright in these images, with the shaded region indicating IAF and the remaining region SF or intra-muscular fat.
Right: Quantiﬁcation of total fat per body weight among the mice examined.
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+/  bone marrow
cells
Xrcc1
+/  mice did not show any gross phenotypes in com-
parison to WT mice by several measurements (see above),
suggesting that the single functional Xrcc1 allele or other
backup DNA repair pathways can cope with natural,
spontaneous DNA damage. We next determined
whether an Xrcc1
+/  state was sufﬁcient to handle the
increased DNA damage expected upon exposure to an
exogenous genotoxin. Towards this end, primary bone
marrow cells were isolated from two WT and two HZ
littermates and challenged with varying doses of the
alkylating agent MMS. As shown in Figure 5, HZ cells
exhibited a statistically signiﬁcant reduction in viability at
1, 3 or 10mM MMS relative to WT controls, indicating a
dose-dependent sensitivity of XRCC1-deﬁcient cells to a
relevant genotoxin.
Exposure-dependent susceptibility of HZ animals
Given the increased sensitivity of Xrcc1
+/  bone marrow
cells to MMS, we evaluated the susceptibility of HZ mice
to exposure-dependent pathologies, employing the
alkylator AOM, in order to replicate a potential environ-
mental challenge. AOM is a pro-carcinogen that is meta-
bolized by cytochrome P450 to methylazoxymethanol, a
chemical intermediate that breaks down to formaldehyde
and a highly reactive alkylating species, likely methyldi-
azonium (28). AOM is known to generate alkylated base
adducts in DNA, such as N
7-methylguanine and O
6-
methylguanine, the latter of which drives G to A transition
mutations. This compound is routinely used experimental-
ly to induce tumorigenesis in the colon of laboratory
animals, and thus, to study the mechanism of cancer
progression and chemoprevention. When Xrcc1
+/  mice
were necropsied 12 weeks after ﬁrst starting the AOM
exposure, grossly observable liver lesions were seen in all
13 HZ mice, but were present in only ﬁve of 15 WT
littermates. The lesions consisted of modular, multifocal
areas of discoloration, which upon histological examin-
ation were areas of necrosis, hepatocellular hyperplasia,
biliary hyperplasia and hypertrophy, and perivascular
inﬂammation (Figure 6A). When assigned a grade of 1–4
(see ‘Materials and Methods’ section), livers from Xrcc1
+/ 
mice had a score of 3.1±0.6, while livers from WT
littermates had a score of 1.3±0.5 (P 0.05) (Figure
6B). In the colon, staining with methylene blue showed
large numbers of aberrant crypt foci, 38±5 per HZ
mouse, compared to only 15±2 for WT mice.
Occasional adenomatous polyps were seen in HZ mice,
but not in WT mice (data not shown). Based on these
ﬁndings, we conclude that Xrcc1
+/  mice are haploin-
sufﬁcient for the toxic and pre-cancerous affects of the
DNA-damaging agent AOM.
DISCUSSION
XRCC1 is a non-enzymatic scaffold protein that facilitates
efﬁcient SSB repair and has been associated with
neurodegenerative disease and cancer susceptibility
(10,17,29). Using Xrcc1
+/  mice, we evaluated longevity
and a series of endpoints related to health span, primarily
in the absence of exposure. In all, XRCC1
haploinsufﬁciency had no overt effect on animal life ex-
pectancy, weight, organ function (as assessed by various
blood chemistries), motor coordination, brain integrity or
memory, body fat composition, bone marrow cellularity,
blood cell composition or morphology, or chromosome
status. The generally normal phenotype of the HZ mice,
including the lack of an obvious increase in spontaneous
neoplasms and the intact chromosome structure, indicate
that  50% XRCC1 protein is largely sufﬁcient to
maintain normal animal ﬁtness and genome integrity in
a controlled, toxin-free environment. The two most no-
ticeable consequences of Xrcc1 heterozygosity were a pro-
pensity for early death, primarily due to abdominal organ
rupture, and an increased susceptibility for liver toxicity
and precancerous lesions in the colon when challenged
with an exogenous agent, i.e. the alkylator AOM.
Figure 5. Cell viability following MMS exposure. Bone marrow cells
were isolated from two WT and two HZ animals, cultured at 20% O2/
5% CO2 in IMDM supplemented with MSF and IL-6, and then
challenged with 0, 0.3, 1, 3 or 10mM MMS. Following treatment,
cells were cultured as above for an additional 48h, WST-1 reagent
was added to the medium for 1h, and the absorbance was measured.
Shown are the average and standard deviations at each treatment
regime of a total of six data points (two mice, three data points
each). Single factor ANOVA analysis determined P-values of 0.55,
<0.01, <0.0001 and <0.01 at 0.3, 1, 3 and 10mM MMS, respectively.
Table 2. Chromosome number (aneuploidy) in WT and HZ Xrcc1
bone marrow cells
Mouse ID No./Genotype No. of
metaphase
counted
No. of
aneuploid
cells
Percentage
of aneuploid
cells
NTH574/WT 58 5 8.6
NTH834/WT 57 1 1.8
NTH567/HZ 47 5 10.6
NTH575/HZ 62 3 4.8
Percentage of aneuploid cells per at least 47 metaphases examined is
shown.
Note: No gross structural chromosome abnormalities were seen in
either the WT or HZ background (data not shown). Chi-square con-
tingency table analysis of the combined data (6 of 115 for WT, 8 of 109
for HZ) reveals P=0.51.
Nucleic Acids Research, 2011,Vol.39, No. 18 8001Although the exact cause of death was undeterminable
in many cases (Table 1), we did observe an occasional
abdominal organ rupture exclusively in HZ male and
female mice at a relatively young age (2–9 months). This
outcome may be related to the essential role that XRCC1,
and presumably BER, plays in embryonic development
(20,30). In particular, a characteristic of Xrcc1 null
(Xrcc1
 / ) E6.5 and E7.5 embryos was an abnormal
morphology of the embryonic endoderm, a germ layer
that ultimately gives rise to the epithelium of the gastro-
intestinal and respiratory tracts, as well as major endo-
crine glands and organs (e.g. the liver and pancreas).
Other extraembryonic tissues including the parietal
endoderm, extraembryonic ectoderm, ectoplacental cone
and trophoblast giant cells appeared healthy in Xrcc1
 / 
embryos, albeit somewhat smaller than normal (20). More
detailed analysis indicated that the lineage-speciﬁc
abnormalities correlated with the amount of unrepaired
DNA damage as detected by the alkaline Comet assay
(20). These observations may suggest that individuals
with a defect in a critical DNA repair process, such as
SSB repair, will be more prone to congenital gastro-
intestinal malformations or other diseases, for example,
of the lung, liver or pancreas.
It is becoming more appreciated that the developmental
dynamics and the ﬁnal integrity of the nervous system
require vigilant DNA repair processes from the beginning,
particularly during the early period of rapid proliferation
when progenitor cells are expanding and differentiating to
generate the complex neural network (31). While our data
did not reveal an overt effect of Xrcc1 heterozygosity on
neurogenesis or brain function, suggesting sufﬁcient SSB
repair or compensatory pathways to cope with spontan-
eous, endogenous DNA damage, there appeared to
be neurological involvement in some of the animals
(Table 1). In fact, the behavior observed in three HZ
mice (i.e. head tilt and impairment of lower leg
movement) is seemingly in line with evidence implicating
XRCC1 in modulating the cerebral response to ischemia
and the risk of stroke in rodents and humans (32–35).
Consistent with XRCC1 and SSB repair playing an im-
portant role in brain function, adult mice, upon inactiva-
tion of Xrcc1 in the nervous system using a Nes-cre
system, exhibit widespread loss of cerebellar interneurons
and abnormal activity in hippocampal neurons, resulting
in pronounced neurological dysfunction characterized
by progressive mild ataxia accompanied by episodic
spasms (16).
Figure 6. AOM-induced liver toxicity. (A) Liver from an Xrcc1
+/  (HZ) mouse shows areas of necrosis and severe multifocal hepatocellular
hyperplasia and hypertrophy, mild vacuolation, karyomegaly, and marked variation of nuclear size with multiple nucleoli. There was moderate
locally extensive multifocal biliary hypertrophy and hyperplasia with biliary dilation and periductal and periportal inﬁltration of mononuclear
inﬂammatory cells, and variable numbers of ﬁbroblasts. Liver from a WT littermate shows some evidence of focal hepatocellular necrosis, with
mild hepatocellular hyperplasia and hypertrophy, and limited perivascular inﬁltration of mononuclear inﬂammatory cells. (B) Number of HZ and
WT mice in each of the different histopathological liver grades (1–4, see ‘Materials and Methods’ section).
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haploinsufﬁciency of XRCC1 in the absence of
exposure, we evaluated the susceptibility of Xrcc1
+/ 
mice to AOM, since many environmental agents have
the capacity to generate DNA lesions that require
XRCC1 for efﬁcient repair. Consistent with evidence
that reduced XRCC1 function may be related to disease
susceptibility, namely cancer risk (24), we found that (i)
Xrcc1
+/  bone marrow cells were hypersensitive to treat-
ments with the alkylator MMS and (ii) HZ mice exposed
to AOM had an increase in aberrant crypt foci in the
colon, which are generally accepted as precancerous
lesions. The fact that we saw an occasional adenomatous
polyp in HZ but not WT mice may be indicative of
increased colon tumors in HZ mice had we monitored
the animals for a longer period of time. In addition, the
rather robust susceptibility of HZ mice treated with AOM
to hepatic lesions further emphasizes that XRCC1 plays
an important role in attenuating alkylating agent-induced
cellular toxicity. The liver has a high propensity for re-
sponding to cellular stress, and it was obvious that the
early liver necrosis in Xrcc1
+/  mice, although not life
threatening, was progressing toward a chronic inﬂamma-
tory condition resembling cirrhosis. These observations
point to haploinsufﬁciency in XRCC1, and a defect in
SSB repair, being a risk factor in exposure-dependent
disease, as well as a need for further evaluation of the
effects of exogenous challenges on risk of Xrcc1 HZ
mice, with an eye towards cancer development and neuro-
logical dysfunction.
XRCC1 has been reported to be exclusively nuclear,
with no mitochondrial localization (8). This restricted
intracellular distribution may in part be why no obesity
was seen in the Xrcc1
+/  mice, as the connection between
NEIL1 deﬁciency and pathologies that resemble hyper-
metabolic syndrome has been argued to stem from a
defect in mitochondrial DNA repair (26). Thus, given
that mitochondrial DNA repair is presumably normal in
Xrcc1
+/  cells, our results imply that the apparent
endodermal-derived developmental malformations,
possible stroke propensity and exposure-dependent sus-
ceptibility are explicitly related to nuclear genome
dynamics.
It remains to be determined if sporadic loss of hetero-
zygosity of XRCC1 in mammals would give rise to more
profound consequences on genome integrity and overall
organ ﬁtness. Interestingly, a previous report found that
an  10% XRCC1 protein level is sufﬁcient to permit
mouse embryogenesis and post-natal development, and
that ﬁbroblasts derived from these transgenic mice
exhibit little or no increased sensitivity to MMS as
determined by a non-quantitative differential cytotoxicity
assay (36). Further evaluation of these hypomorph
animals revealed that they are consistently smaller than
their littermates ( 25% reduction in body weight), sug-
gesting an effect of XRCC1 deﬁciency that is not presently
understood (17). Looking forward, it would be of interest
to investigate the phenotype of the XRCC1 hypomorph
animals in greater detail, both with and without exposure,
as well as how speciﬁc alterations in XRCC1 function
would affect gross pathological outcomes using additional
mouse models. For example, two mouse lines have been
generated that express a strategic point mutation in either
the N-terminal or BRCT1 domain of XRCC1 that
disrupts the interaction with POLb or PARP1, respect-
ively [(17) and unpublished data]. Using these models,
it will be possible to determine the precise role of the
different XRCC1 molecular functions to any associated
disease development.
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